Is prophylactic lymph node dissection efficacious in salvage esophagectomy after definitive chemoradiotherapy?

被引:0
作者
Kuriyama, Kengo [1 ]
Okamura, Akihiko [1 ]
Hayami, Masaru [1 ]
Kanamori, Jun [1 ]
Tamura, Masahiro [1 ]
Takahashi, Naoki [1 ]
Terayama, Masayoshi [1 ]
Kanie, Yasukazu [1 ]
Maruyama, Suguru [1 ]
Watanabe, Masayuki [1 ]
机构
[1] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Surg, 3-8-31 Ariake,Koto ku, Tokyo 1358550, Japan
关键词
definitive chemoradiotherapy; efficacy index; esophageal cancer; postoperative complications; prophylactic lymph node dissection; salvage esophagectomy; SQUAMOUS-CELL CARCINOMA; CLINICAL-SIGNIFICANCE; CANCER; CLASSIFICATION; NIVOLUMAB; DIAGNOSIS; THERAPY;
D O I
10.1093/dote/doaf004
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Salvage esophagectomy for esophageal cancer after definitive chemoradiotherapy (dCRT) is a high-risk surgery, and radical lymph node dissection (RLND) can cause severe complications. However, the significance of RLND in salvage surgery remains unclear.Methods This study included 55 patients who underwent curative-intent salvage esophagectomy after dCRT for esophageal squamous cell carcinoma. We evaluated the prognostic impact of lymph node dissection of each station using efficacy indexes (EIs) and compared the outcomes between RLND and limited lymph node dissection (LLND).Results Nine (16.4%) patients underwent RLND and 46 (83.6%) underwent LLND. Patients who underwent RLND had greater operative blood loss and a greater number of resected lymph nodes compared to patients who underwent LLND (P = 0.053 and 0.002, respectively). However, the incidence of postoperative complications was not significantly different between the groups. The EIs of the cervical and mediastinal lymph nodes were zero because no patients with involved nodes at these stations remained alive at 5 years. In contrast, perigastric lymph nodes had relatively high EIs. Overall and cancer-specific survival did not differ significantly between patients who underwent RLND and those who underwent LLND (P = 0.475 and 0.808, respectively).Conclusions The EIs of the cervical and mediastinal lymph nodes were zero, and RLND did not improve survival. Depending on tumor status, LLND may be sufficient for salvage esophagectomy.
引用
收藏
页数:8
相关论文
共 35 条
[1]   Waiting to Operate The Risk of Salvage Esophagectomy [J].
Boerner, Thomas ;
Harrington, Caitlin ;
Tan, Kay See ;
Adusumilli, Prasad S. ;
Bains, Manjit S. ;
Bott, Matthew J. ;
Downey, Robert J. ;
Huang, James ;
Ilson, David H. ;
Isbell, James M. ;
Janjigian, Yelena Y. ;
Park, Bernard J. ;
Rocco, Gaetano ;
Rusch, Valerie W. ;
Sihag, Smita ;
Wu, Abraham J. ;
Jones, David R. ;
Molena, Daniela .
ANNALS OF SURGERY, 2023, 277 (05) :781-788
[2]  
Booka E, 2020, ANN SURG ONCOL, V27, P3163, DOI 10.1245/s10434-020-08440-7
[3]   The Clavien-Dindo Classification of Surgical Complications Five-Year Experience [J].
Clavien, Pierre A. ;
Barkun, Jeffrey ;
de Oliveira, Michelle L. ;
Vauthey, Jean Nicolas ;
Dindo, Daniel ;
Schulick, Richard D. ;
de Santibanes, Eduardo ;
Pekolj, Juan ;
Slankamenac, Ksenija ;
Bassi, Claudio ;
Graf, Rolf ;
Vonlanthen, Rene ;
Padbury, Robert ;
Cameron, John L. ;
Makuuchi, Masatoshi .
ANNALS OF SURGERY, 2009, 250 (02) :187-196
[4]   Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma [J].
Doki, Y. ;
Ajani, J. A. ;
Kato, K. ;
Xu, J. ;
Wyrwicz, L. ;
Motoyama, S. ;
Ogata, T. ;
Kawakami, H. ;
Hsu, C. -H. ;
Adenis, A. ;
El Hajbi, F. ;
Di Bartolomeo, M. ;
Braghiroli, M. I. ;
Holtved, E. ;
Ostoich, S. A. ;
Kim, H. R. ;
Ueno, M. ;
Mansoor, W. ;
Yang, W. -C. ;
Liu, T. ;
Bridgewater, J. ;
Makino, T. ;
Xynos, I. ;
Liu, X. ;
Lei, M. ;
Kondo, K. ;
Patel, A. ;
Gricar, J. ;
Chau, I. ;
Kitagawa, Y. .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (05) :449-462
[5]   Japanese Classification of Esophageal Cancer, 12th Edition: Part II [J].
Doki, Yuichiro ;
Tanaka, Koji ;
Kawachi, Hiroshi ;
Shirakawa, Yasuhiro ;
Kitagawa, Yuko ;
Toh, Yasushi ;
Yasuda, Takushi ;
Watanabe, Masayuki ;
Kamei, Takashi ;
Oyama, Tsuneo ;
Seto, Yasuyuki ;
Murakami, Kentaro ;
Arai, Tomio ;
Muto, Manabu ;
Mine, Shinji .
ESOPHAGUS, 2024, 21 (03) :216-269
[6]   A meta-analysis on salvage surgery as a potentially curative procedure in patients with isolated local recurrent or persistent esophageal cancer after chemoradiotherapy [J].
Faiz, Z. ;
Dijksterhuis, W. P. M. ;
Burgerhof, J. G. M. ;
Muijs, C. T. ;
Mul, V. E. M. ;
Wijnhoven, B. P. L. ;
Smit, J. K. ;
Plukker, J. T. M. .
EJSO, 2019, 45 (06) :931-940
[7]   Inter-evaluator heterogeneity of clinical diagnosis for locally advanced esophageal squamous cell carcinoma [J].
Hamamoto, Yasuo ;
Nojima, Masanori ;
Aoki, Yu ;
Suzuki, Takeshi ;
Kawasaki, Kenta ;
Hirata, Kenro ;
Sukawa, Yasutaka ;
Kasuga, Akira ;
Kawakubo, Hirofumi ;
Takeuchi, Hiroya ;
Murakami, Koji ;
Takaishi, Hiromasa ;
Kanai, Takanori ;
Kitagawa, Yuko .
ESOPHAGUS, 2017, 14 (04) :324-332
[8]   Patient selection for salvage surgery after definitive chemoradiotherapy in esophageal squamous cell carcinoma [J].
Harada, Hiroki ;
Yamashita, Keishi ;
Katada, Chikatoshi ;
Ishiyama, Hiromichi ;
Soeno, Takafumi ;
Washio, Marie ;
Sakuraya, Mikiko ;
Ushiku, Hideki ;
Niihara, Masahiro ;
Hosoda, Kei ;
Hiki, Naoki .
LANGENBECKS ARCHIVES OF SURGERY, 2020, 405 (06) :767-776
[9]   Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus [J].
Ishikura, S ;
Nihei, K ;
Ohtsu, A ;
Boku, N ;
Hironaka, S ;
Mera, K ;
Muto, M ;
Ogino, TG ;
Yoshida, S .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (14) :2697-2702
[10]   Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial [J].
Kato, Ken ;
Cho, Byoung Chul ;
Takahashi, Masanobu ;
Okada, Morihito ;
Lin, Chen-Yuan ;
Chin, Keisho ;
Kadowaki, Shigenori ;
Ahn, Myung-Ju ;
Hamamoto, Yasuo ;
Doki, Yuichiro ;
Yen, Chueh-Chuan ;
Kubota, Yutaro ;
Kim, Sung-Bae ;
Hsu, Chih-Hung ;
Holtved, Eva ;
Xynos, Ioannis ;
Kodani, Mamoru ;
Kitagawa, Yuko .
LANCET ONCOLOGY, 2019, 20 (11) :1506-1517